Zealand Pharma A/S Ord
(ZLDPF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -156,430 | -102,183 | -170,222 | -161,988 | -129,719 |
| Depreciation Amortization | 3,748 | 3,643 | 16,703 | 6,404 | 6,540 |
| Accounts receivable | -7,099 | -981 | 2,580 | -10,261 | -1,182 |
| Accounts payable and accrued liabilities | 13,038 | 5,784 | -8,305 | -7,805 | 18,375 |
| Other Working Capital | 17,745 | 7,565 | 1,453 | -26,462 | 14,986 |
| Other Operating Activity | -5,969 | 24,365 | 24,374 | 7,288 | -14,511 |
| Operating Cash Flow | $-134,968 | $-61,807 | $-133,417 | $-192,825 | $-105,511 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,061,366 | -155,405 | 26,420 | 638 | -609 |
| PPE Investments | -1,458 | -1,632 | -1,658 | -3,521 | -3,837 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -25,706 |
| Purchase Sale Intangibles | -449 | -1,816 | N/A | N/A | N/A |
| Other Investing Activity | -449 | -1,816 | 15,064 | 0 | 0 |
| Investing Cash Flow | $-1,063,273 | $-158,854 | $39,826 | $-2,883 | $-30,151 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 53,631 | N/A | N/A | 103,082 | N/A |
| Common Stock Issued | 1,235,904 | 227,086 | 153,588 | 123,310 | 127,595 |
| Common Stock Repurchased | -51,016 | -6,040 | N/A | -4,549 | N/A |
| Other Financing Activity | -36,688 | -89,347 | -70,412 | -9,802 | -11,019 |
| Financing Cash Flow | $1,201,831 | $131,698 | $83,176 | $212,041 | $116,576 |
| Exchange Rate Effect | 904 | -1,051 | 1,938 | 10,536 | 573 |
| Beginning Cash Position | 65,150 | 155,253 | 159,881 | 152,771 | 165,618 |
| End Cash Position | 69,644 | 65,240 | 151,404 | 179,640 | 147,106 |
| Net Cash Flow | $4,494 | $-90,013 | $-8,478 | $26,869 | $-18,513 |
| Free Cash Flow | |||||
| Operating Cash Flow | -134,968 | -61,807 | -133,417 | -192,825 | -105,511 |
| Capital Expenditure | -1,458 | -1,632 | -1,658 | -3,521 | -3,837 |
| Free Cash Flow | -136,426 | -63,439 | -135,075 | -196,346 | -109,348 |